Close

BofA Securities Resumes Amgen (AMGN) at Underperform

December 10, 2024 6:47 AM EST Send to a Friend
BofA Securities analyst Tim Anderson resumes coverage on Amgen (NASDAQ ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login